This site is intended for UK healthcare professionals only.
(This site may contain promotional material)
Spider, Reticular & Varicose Vein Sclerotherapy Treatment
- Highly Effective Clearance4,5
- Local Anaesthetic1,2,3
- ‘Extremely Well Tolerated’6
- Patient Satisfaction5
Contact us at info@korahealthcare.com or on 01904 217 755
References
- https://www.medicines.org.uk/emc/product/11567
- https://www.medicines.org.uk/emc/product/11568
- https://www.medicines.org.uk/emc/product/11570
- Conrad et al. Dermatol Surg 1995, 21: 334-336
- Rabe et al. Sclerotherapy Phlebology 2010, 25: 124-1311
- Eckmann. Expert Opin Investig Drugs 2009, 8(12): 1919-1927
Marketing Authorisation Numbers: Aethoxysklerol 5mg/ml – PL 39972/0021, Aethoxysklerol 10 mg/ml – PL 39972/0022, Aethoxysklerol 30 mg/ml – PL 39972/0023.
Adverse events should be reported.
Adverse events should also be reported to Kora Healthcare at pv@korahealthcare.com or on 01904 217 755
Reporting forms and information can be found at https:/yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Kora Healthcare at pv@korahealthcare.com or on 01904 217 755